SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-021038
Filing Date
2018-08-09
Accepted
2018-08-09 16:07:07
Documents
40
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q wve-10q_20180630.htm 10-Q 1164432
2 EX-31.1 wve-ex311_11.htm EX-31.1 14702
3 EX-31.2 wve-ex312_7.htm EX-31.2 15041
4 EX-32 wve-ex32_10.htm EX-32 9202
5 GRAPHIC goayk3ab0yoa000001.jpg GRAPHIC 43731
  Complete submission text file 0001564590-18-021038.txt   3787857

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT wve-20180630.xml EX-101.INS 702240
7 XBRL TAXONOMY EXTENSION SCHEMA wve-20180630.xsd EX-101.SCH 27543
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE wve-20180630_cal.xml EX-101.CAL 33243
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wve-20180630_def.xml EX-101.DEF 85937
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE wve-20180630_lab.xml EX-101.LAB 214901
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wve-20180630_pre.xml EX-101.PRE 165283
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37627 | Film No.: 181005060
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences